Apoptosis is accompanied by water loss, shrinkage of the cell, and enzymatic fixation of the membrane, whereas necrosis is not. Necrotic and apoptotic cells differ, therefore, both in differential light scattering and in the antigenic make-up of the cell membrane.
We describe a quantitative and sensitive flow cytometric method10
for the detection of human apoptotic lymphocytes that, unlike previously
published assays, allows their identification in mixed populations of peripheral
bloood leukocytes as well as their immunophenotyping. This method is based
on integration of differential light scatter parameters (Forward Scatter
vs Side Scatter in linear amplification) with apparent density of CD45
(dim vs bright in logaritmic amplification) membrane fluorescence. Apoptotic
lymphocytes are identified on the basis of peculiar light scatter changes,
reflecting their smaller size and their modified nucleus/cytoplasm organization,
and of the decreased fluorescence intensity of surface CD45. Furthermore,
apoptotic cells cen be electronically gated (CD45 intensity vs light scatter)
and characterized phenotypically by tow or tree colour staining.
2.2 Staining with MoAbs (basic protocol). For each determination, 5x105 nucleated cells in 50 µl of RPMI 1640 with 10% fetal calf serum (complete medium, A2) are single, double or triple-stained with anti-CD45 fluorescein isothiocyanate (FITC) conjugated (A2) and different phycoerythrin (PE) or red emitting fluorocrome (e.g.: peridinchlorophyll protein, PerCP) conjugated MoAbs, at 4°C for 30 minutes, using saturating amounts of antibody experimentally determined for each MoAb. After one wash the cells are resuspended in complete medium and directly analyzed by flow cytometry or stained for membrane permeability (support protocol).
Staining with dyes (support protocol). Membrane permeability, as an indicator of late apoptosis and cell death, is evaluated by staining with propidium iodide (PI, A2), when cells are CD45-FITC single stained, and by 7-amino-actinomycin D (7-AAD, A2) when membrane double staining (CD45FITC/CD"X"PE) is performed. The intercalative dyes are used at 1 mg/ml in complete medium, incubated at 4°C for 30 minutes and analyzed without further washings.
2.3 Data analysis. On biparametric scattergram of 10,000 events, gated for CD45 positivity and acquired in list mode, are defined two different regions: one includes apoptotic cells with lower size and apparent greater complexity (low FW-SC and high RT-SC), and another includes events with differential light scatters (DLS) property typical of viable cells. The percentage of apoptotic cells is calculated on the basis of the number of CD45dim cells in apoptotic region versus the total number of CD45+ cells in both regions. An objective boundary between CD45dim and CD45bright cells is determinated using Kolmogorov-Smirnov statistics on the overlayed CD45 fluorescence intensity histograms of the two regions, taking as the cut-off point the fluorescence channel with maximum difference between the two histograms.
The same procedure can be applied on cells belonging to defined subpopulations
identified by staining with antisubset antibodies in combination with anti-CD45.
In these cases a logical gate including scatter region, CD45 and a given
subset marker must be defined. In the same way is possible to evaluate
the membrane permeability by intercalative dyes, taking account that PI
is compatible with FITC fluorescence only while 7-AAD can be used with
FITC and PE stained cells.
3.1 Background Information.
To obtain a good performance using this assay two parameters are critical. A daily check up of the cytometer alignment and fluidic, must be done using standard microbeads to verify the scatter and fluorescence coefficient of variation (CV).
The other critical parameter is the CD45 histogram sharpness. In our hands FITC conjugated MoAbs to leukocyte common antigen showed best results. The reactive quality can be evaluated by the resolution degree of CD45 intensity histograms of lymphocytes, granulocytes and monocytes.
3.2 Key References.
2. Darzynkiewicz Z., Bruno S., Del Bino G., Gorczyca W., Hotz MA., Lassota P., Traganos F. 1992. Features of apoptotic cells measured by flow cytometry. Cytometry 13:795.
3. Nicoletti I., Migliorati G., Pagliacci MC., Grignani F., RiccardiC. 1991. A rapid and simple method for measuring thymocyte apoptosis by propidium iodide staining and flow cytometry. J. Immunol. Methods 139:271.
4. Ormerod MG., Collins MKL., Rodriguez-Tarduchy G., Robertson D. 1992. Apoptosis in interleukin-3-dependent haematopoietic cells: Quantitation by two flow cytometric methods. J. Immunol. Methods 153:57.
5. Dive C., Gregory CD., Phipps DJ., Evans DL., Milner AE., Wyllie AH.1992. Analysis and discrimination of necrosis and apoptosis (programmed cell death) by multiparameter flow cytometry. Biochim. Biophys Acta 1133:275.
6. Lyons BA., Samuel K., Sanderson A., Maddy AH. 1992. Simultaneous analysis of immunophenotype and apoptosis of murine thymocytes by single laser flow cytometry. Cytometry 13:809.
7. Swat W., Ignatowicz L., Kisielow P. 1991. Detection of apoptosis of immature CD4+8+ thymocytes by flow cytometry. J. Immunol. Methods 137:79.
8. Schmid I., Krall WJ., Uittenbogaart CH., Braun J., Giorgi JV. 1992. Dead cell discrimation with 7-amino-actinomycin D in combination with dual color immunofluorescence in single laser flow cytometry. Cytometry 13:204.
9. Telford WG., King LE., Fraker PJ. 1992. Comparative evaluation of several DNA binding dyes in the detection of apoptosis-associated chromatin degradation by flow cytometry. Cytometry 13:137.
10. Carbonari M., Cibati M., Cherchi M., Sbarigia D., Pesce AM., Dell'Anna L., Modica A., Fiorilli M. 1994. Detection and characterization of apoptotic peripheral blood lymphocytes in human immunodeficiency virus infection and cancer chemotherapy by a novel flow immunocytometric method. Blood 83:1268.
Anti-CD45: FITC cod. 347463 Becton-Dickinson, San Jose CA
Fetal Calf Serum: Biochrom KG, Berlin, Germany
RPMI 1640: Gibco, Grand Island, NY
PI: cod. P-1304; Molecular Probes Inc, Eugene, OR
Appendix 2: Equipment
Cytoron Absolute: Ortho Diagnostic Systems, Raritan, NJ
FACScan: Becton Dickinson, San Jose, CA
FACScalibur: Becton Dickinson, San Jose,CA